Tax driver steers pharma M&A

Save

No sooner has the dust settled on Pfizer's for now thwarted bid for AstraZeneca than the next US big pharma arrives on the other side of the Atlantic with a proposal to make. This time it's AbbVie, making a play for Shire, with which, on the face of it,…